{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:54:19Z","timestamp":1792457659715,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11060-026-05460-3","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:02:45Z","timestamp":1771045365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Meta-analysis of treatment-emergent seizures in glioma vaccine trials"],"prefix":"10.1007","volume":"176","author":[{"given":"Louise","family":"Mc Carthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Y.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-8398","authenticated-orcid":false,"given":"Steven","family":"Tobochnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"5460_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392:432\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(18)30990-5","journal-title":"Lancet"},{"issue":"1","key":"5460_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/neuonc\/noad154","volume":"26","author":"EK Avila","year":"2024","unstructured":"Avila EK, Tobochnik S, Inati SK, Koekkoek JAF, McKhann GM, Riviello JJ, Rud\u00e0 R, Schiff D, Tatum WO, Templer JW, Weller M, Wen PY (2024) Brain tumor-related epilepsy management: A society for Neuro-oncology (SNO) consensus review on current management. Neuro Oncol 26(1):7\u201324. https:\/\/doi.org\/10.1093\/neuonc\/noad154","journal-title":"Neuro Oncol"},{"issue":"1","key":"5460_CR3","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41467-025-60074-z","volume":"16","author":"T Nejo","year":"2025","unstructured":"Nejo T, Krishna S, Yamamichi A, Lakshmanachetty S, Jimenez C, Lee KY, Baker DL, Young JS, Chen T, Phyu SSS, Phung L, Gallus M, Maldonado GC, Okada K, Ogino H, Watchmaker PB, Diebold D, Choudhury A, Daniel AGS, Cadwell CR, Raleigh DR, Hervey-Jumper SL, Okada H (2025) Glioma-neuronal circuit remodeling induces regional immunosuppression. Nat Commun 16(1):4770. https:\/\/doi.org\/10.1038\/s41467-025-60074-z","journal-title":"Nat Commun"},{"issue":"7775","key":"5460_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","volume":"573","author":"V Venkataramani","year":"2019","unstructured":"Venkataramani V, Tanev DI, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T, K\u00f6rber C, Kardorff M, Ratliff M, Xie R, Horstmann H, Messer M, Paik SP, Knabbe J, Sahm F, Kurz FT, Acikg\u00f6z AA, Herrmannsd\u00f6rfer F, Agarwal A, Bergles DE, Chalmers A, Miletic H, Turcan S, Mawrin C, H\u00e4nggi D, Liu HK, Wick W, Winkler F, Kuner T (2019) Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature 573(7775):532\u2013538. https:\/\/doi.org\/10.1038\/s41586-019-1564-xEpub 2019 Sep 18","journal-title":"Nature"},{"issue":"7775","key":"5460_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"HS Venkatesh","year":"2019","unstructured":"Venkatesh HS, Morishita W, Geraghty AC, Silverbush D, Gillespie SM, Arzt M, Tam LT, Espenel C, Ponnuswami A, Ni L, Woo PJ, Taylor KR, Agarwal A, Regev A, Brang D, Vogel H, Hervey-Jumper S, Bergles DE, Suv\u00e0 ML, Malenka RC, Monje M (2019) Electrical and synaptic integration of glioma into neural circuits. Nature 573(7775):539\u2013545. https:\/\/doi.org\/10.1038\/s41586-019-1563-yEpub 2019 Sep 18","journal-title":"Nature"},{"key":"5460_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","volume":"7","author":"A Vezzani","year":"2011","unstructured":"Vezzani A, French J, Bartfai T, Baram TZ (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7:31\u201340. https:\/\/doi.org\/10.1038\/nrneurol.2010.178","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"5460_CR7","doi-asserted-by":"publisher","first-page":"e174753","DOI":"10.1172\/jci.insight.174753","volume":"9","author":"S Tripathi","year":"2024","unstructured":"Tripathi S, Nathan CL, Tate MC, Horbinski CM, Templer JW, Rosenow JM, Sita TL, James CD, Deneen B, Miller SD, Heimberger AB (2024) The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions. JCI Insight 9(1):e174753. https:\/\/doi.org\/10.1172\/jci.insight.174753","journal-title":"JCI Insight"},{"issue":"7","key":"5460_CR8","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41593-022-01095-5","volume":"25","author":"P Kumar","year":"2022","unstructured":"Kumar P, Lim A, Hazirah SN, Chua CJH, Ngoh A, Poh SL, Yeo TH, Lim J, Ling S, Sutamam NB, Petretto E, Low DCY, Zeng L, Tan EK, Arkachaisri T, Yeo JG, Ginhoux F, Chan D, Albani S (2022) Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling. Nat Neurosci 25(7):956\u2013966. https:\/\/doi.org\/10.1038\/s41593-022-01095-5Epub 2022 Jun 23","journal-title":"Nat Neurosci"},{"key":"5460_CR9","doi-asserted-by":"publisher","unstructured":"\u00c7ar\u00e7ak N, Al Maawal S, Thergarajan P, Tan THL, Mehta VK, Baker T, Henshall DC, Galanopoulou AS, Akman \u00d6, Casillas-Espinosa PM, Sankar R, Librizzi L, Handel AE WONOEP XVII appraisal: the immunopathogenesis of epilepsy. Epilepsia 2025. https:\/\/doi.org\/10.1111\/epi.70027. Epub 2025 Nov 22.","DOI":"10.1111\/epi.70027"},{"key":"5460_CR10","doi-asserted-by":"publisher","unstructured":"Avila EK, Reiner AS, Armstrong TS, Aaroe AE, Cunningham EM, Brown JG, Bruno F, Diarte J, Haggiagi A, Harrison RA, Joanta-Gomez A, Koekkoek JAF, Lee EQ, Le Rhun E, Miller H, Panageas KS, Peguero EN, Ruda R, Soffietti R, Templer JW, Tobochnik S, Vera E, Vogelbaum MA, Weller M, van den Bent M (2025 Jul) RANO seizure working group-tumor related epilepsy assessment tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice. Neuro Oncol 12:noaf165. https:\/\/doi.org\/10.1093\/neuonc\/noaf165","DOI":"10.1093\/neuonc\/noaf165"},{"issue":"12","key":"5460_CR11","doi-asserted-by":"publisher","first-page":"e168035","DOI":"10.1172\/JCI168035","volume":"133","author":"MR Drumm","year":"2023","unstructured":"Drumm MR, Wang W, Sears TK, Bell-Burdett K, Javier R, Cotton KY, Webb B, Byrne K, Unruh D, Thirunavu V, Walshon J, Steffens A, McCortney K, Lukas RV, Phillips JJ, Mohamed E, Finan JD, Santana-Santos L, Heimberger AB, Franz CK, Kurz J, Templer JW, Swanson GT, Horbinski C (2023) Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors. J Clin Invest 133(12):e168035","journal-title":"J Clin Invest"},{"issue":"2","key":"5460_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/neuonc\/noad176","volume":"26","author":"S Tobochnik","year":"2024","unstructured":"Tobochnik S, Dorotan MKC, Ghosh HS, Lapinskas E, Vogelzang J, Reardon DA, Ligon KL, Bi WL, Smirnakis SM, Lee JW (2024) Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro Oncol 26(2):323\u2013334","journal-title":"Neuro Oncol"},{"key":"5460_CR13","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-018-0172-x","volume":"24","author":"HY Koh","year":"2018","unstructured":"Koh HY, Kim SH, Jang J, Kim H, Han S, Lim JS et al (2018) BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors. Nat Med 24:1662\u20131668","journal-title":"Nat Med"},{"issue":"5","key":"5460_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.neuron.2023.01.013","volume":"111","author":"RN Curry","year":"2023","unstructured":"Curry RN, Aiba I, Meyer J et al (2023) Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation. Neuron 111(5):682\u2013695e9","journal-title":"Neuron"},{"key":"5460_CR15","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/j.1528-1167.2011.03111.x","volume":"52","author":"L Conti","year":"2011","unstructured":"Conti L, Palma E, Roseti C, Lauro C, Cipriani R, de Groot M et al (2011) Anomalous levels of Cl\u2013 transporters cause a decrease of GABAergic Inhibition in human peritumoral epileptic cortex. Epilepsia 52:1635\u20131644","journal-title":"Epilepsia"},{"key":"5460_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tins.2007.07.006","volume":"30","author":"CM Dub\u00e9","year":"2007","unstructured":"Dub\u00e9 CM, Brewster AL, Richichi C, Zha Q, Baram TZ (2007) Fever, febrile seizures and epilepsy. Trends Neurosci 30:490\u2013496. https:\/\/doi.org\/10.1016\/j.tins.2007.07.006","journal-title":"Trends Neurosci"},{"issue":"1","key":"5460_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12974-020-01854-w","volume":"17","author":"S Mukherjee","year":"2020","unstructured":"Mukherjee S, Arisi GM, Mims K, Hollingsworth G, O\u2019Neil K, Shapiro LA (2020) Neuroinflammatory mechanisms of post-traumatic epilepsy. J Neuroinflammation 17(1):193","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5460_CR18","doi-asserted-by":"publisher","first-page":"13661","DOI":"10.1038\/s41598-024-63541-7","volume":"14","author":"XQ Che","year":"2024","unstructured":"Che XQ, Zhan SK, Song JJ, Deng YL, Wei-Liu, Peng-Huang, Jing-Zhang, Sun ZF, Che ZQ, Liu J (2024) Altered immune pathways in patients of temporal lobe epilepsy with and without hippocampal sclerosis. Sci Rep 14(1):13661. https:\/\/doi.org\/10.1038\/s41598-024-63541-7","journal-title":"Sci Rep"},{"issue":"9","key":"5460_CR19","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/j.1528-1167.2010.02547.x","volume":"51","author":"A Iyer","year":"2010","unstructured":"Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, Gorter JA, Aronica E (2010) Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51(9):1763\u20131773. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02547.x","journal-title":"Epilepsia"},{"issue":"6","key":"5460_CR20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/nan.12736","volume":"47","author":"TS Zimmer","year":"2021","unstructured":"Zimmer TS, Broekaart DWM, Luinenburg M, Mijnsbergen C, Anink JJ, Sim NS, Michailidou I, Jansen FE, van Rijen PC, Lee JH, Fran\u00e7ois L, van Eyll J, Dedeurwaerdere S, van Vliet EA, M\u00fchlebner A, Mills JD, Aronica E (2021) Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol 47(6):826\u2013839. https:\/\/doi.org\/10.1111\/nan.12736Epub 2021 Jun 8","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"5460_CR21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/epi.18261","volume":"66","author":"R Balthazard","year":"2025","unstructured":"Balthazard R, Drouin-Engler RM, Bertrand S, Zine-Eddine F, Li J, Tastet O, Daigneault A, Mamane VH, Ortega-Delgado GG, Sreng Flores AM, Kaufmann DE, Major P, House AA, L\u00e9tourneau-Guillon L, Arbour N, Keezer MR, Larochelle C (2025) Distinct peripheral pro-inflammatory profile associated with tuberous sclerosis complex and epilepsy. Epilepsia 66(4):1288\u20131303. https:\/\/doi.org\/10.1111\/epi.18261Epub 2025 Jan 16","journal-title":"Epilepsia"},{"issue":"17","key":"5460_CR22","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","volume":"30","author":"EG Hughes","year":"2010","unstructured":"Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30(17):5866\u20135875","journal-title":"J Neurosci"},{"key":"5460_CR23","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.1038\/ncomms11153","volume":"7","author":"T Schneider-Hohendorf","year":"2016","unstructured":"Schneider-Hohendorf T, Mohan H, Bien C et al (2016) CD8\u2009+\u2009T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing. Nat Commun 7:11153","journal-title":"Nat Commun"},{"issue":"2","key":"5460_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1158\/2326-6066.CIR-13-0028","volume":"1","author":"T Doucette","year":"2013","unstructured":"Doucette T, Rao G, Rao A, Shen L, Aldape K, Wei J, Dziurzynski K, Gilbert M, Heimberger AB (2013) Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas. Cancer Immunol Res 1(2):112\u2013122. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0028","journal-title":"Cancer Immunol Res"},{"issue":"8070","key":"5460_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-025-08997-x","volume":"643","author":"C Faust Akl","year":"2025","unstructured":"Faust Akl C, Andersen BM, Li Z, Giovannoni F, Diebold M, Sanmarco LM, Kilian M, Fehrenbacher L, Pernin F, Rone JM, Lee HG, Piester G, Kenison JE, Lee JH, Illouz T, Polonio CM, Srun L, Martinez J, Chung EN, Sch\u00fcle A, Plasencia A, Li L, Ferrara K, Lewandrowski M, Strathdee CA, Lerner L, Qu\u00e9va C, Clark IC, Deneen B, Lieberman J, Sherr DH, Antel JP, Wheeler MA, Ligon KL, Chiocca EA, Prinz M, Reardon DA, Quintana FJ (2025) Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity. Nature 643(8070):219\u2013229. https:\/\/doi.org\/10.1038\/s41586-025-08997-xEpub 2025 May 21","journal-title":"Nature"},{"issue":"8078","key":"5460_CR26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41586-025-09191-9","volume":"644","author":"BM Andersen","year":"2025","unstructured":"Andersen BM, Faust Akl C, Wheeler MA, Li Z, Diebold M, Kilian M, Rone JM, Misra A, Kenison JE, Lee JH, Lee HG, Polonio CM, Merrell D, Weiss JH, Godinez L, Piester G, Illouz T, Ye JJ, Ghia A, Martinez J, Chung EN, Srun L, Farrenkopf D, Flausino LE, Sch\u00fcle AM, Sanmarco LM, Giovannoni F, Fehrenbacher L, Charabati M, Guti\u00e9rrez-V\u00e1zquez C, Cusick MM, Prabhakar PS, Bossi CC, Lapinskas E, Nowarski R, Getz G, Ligon KL, Prinz M, Chiocca EA, Reardon DA, Quintana FJ (2025) Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions. Nature 644(8078):1097\u20131106. https:\/\/doi.org\/10.1038\/s41586-025-09191-9Epub 2025 Jun 25","journal-title":"Nature"},{"issue":"6","key":"5460_CR27","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1158\/1078-0432.CCR-23-0430","volume":"30","author":"X Guo","year":"2024","unstructured":"Guo X, Qiu W, Li B, Qi Y, Wang S, Zhao R, Cheng B, Han X, Du H, Pan Z, Zhao S, Qiu J, Li G, Xue H (2024) Hypoxia-Induced neuronal activity in glioma patients polarizes microglia by potentiating RNA m6A demethylation. Clin Cancer Res 30(6):1160\u20131174","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05460-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:47:21Z","timestamp":1772102841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05460-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5460"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05460-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an analysis of previously published, publicly available, de-identified aggregate data, and is exempt from IRB review. The study did not involve human subjects research requiring ethics approval or informed consent procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"P.Y.W. has received research support Astra Zeneca, Black Diamond, Bristol Meyers Squibb, Chimerix, Eli Lily, Erasca, Global Coalition For Adaptive Research, MediciNova, Merck, Nerviano, Novartis, Philogen, Quadriga, Servier, and advisory board\/consulting payments from Alexion\/Astra Zeneca, Black Diamond, Chimerix, Day One Bio, Fore Biotherapeutics, Genenta, Glaxo Smith Kline, Imvax, Merck, Nerviano, Nuvation Bio, Medical Sciences, Novartis, Novocure, Nuvation Bio, Rigel, Sapience, Servier, Telix. D.A.R. has received research support from Agenus, Inc., Ashvattha Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Corbus Pharma, EMD Serono, Enterome, InvIOs, Medicenna Therapeutics, Mogling Bio, Neotx Ltd., Numiera Therapeutics, Sapience Therapeutics, SphereBio, Vaccinex, and advisory board\/consulting payments from AnHeart Pharmaceuticals, BlueRock Thereapeutics PP, CeCaVaGmbH & Co KG., Neuvogen, Putnam Inizii Associates LLc, Chimeric Therapeutics, Miltenyi, Servier, Genenta, Enterome, Kintara, Kiyatec, Novocure, Sumitono Dainippon Pharma, Vivacitas Oncology, Inc. S.T. has received research support from Eisai, and advisory board\/consulting payments from Blackrock Neurotech. The rest of the authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}